Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 15, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 17, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001061983-26-000020
Filed / recorded
Mar 17, 2026, 8:03 PM UTC
Added to OQRO
Oct 6, 2026, 7:14 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
CYTOKINETICS INC
Issuer CIK
1061983
Ticker
CYTK
Reporting person
Fady Ibraham Malik
Relationship
Officer
Officer title
EVP Research & Development
Security
Non-Qualified Stock Option (Right to Buy)
Table
Derivative (Table II)
Transaction date
Mar 15, 2026
Transaction code
A
Shares / units
39,527
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
39,527
Ownership form
Direct
Amendment
No
Footnotes from the filing
Annual equity award comprised of stock options that vest in 48 equal monthly installments, subject to officer's continued employment with the company on each vesting date. Stock options are subject to the company's Amended and Restated 2004 Equity Incentive Plan.